• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贲门失弛缓症患者经气囊扩张治疗后的临床结局:单中心经验

Clinical Outcomes of Patients with Achalasia Following Pneumatic Dilation Treatment: A Single Center Experience.

作者信息

Sabljić Viktorija, Božić Dorotea, Aličić Damir, Ardalić Žarko, Olić Ivna, Bonacin Damir, Žaja Ivan

机构信息

Institute of Emergency Medicine of Šibenik-Knin County, Narodnog Preporoda 1, 22000 Šibenik, Croatia.

Department of Gastroenterology and Hepatology, University Hospital Split, Spinčićeva 1, 21000 Split, Croatia.

出版信息

J Clin Med. 2025 Aug 2;14(15):5448. doi: 10.3390/jcm14155448.

DOI:10.3390/jcm14155448
PMID:40807069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12347232/
Abstract

Pneumatic dilation (PD) is a widely used treatment modality in the management of achalasia. It is particularly relevant in regions where many centers lack access to advanced therapeutic modalities. Therefore, we aimed to assess the effectiveness and safety of PD in our local region. : This study retrospectively analyzed patients with achalasia that underwent PD from 1/2013 to 12/2019. The diagnosis of achalasia was established on the grounds of clinical symptoms, radiological and endoscopic findings, and esophageal manometry. Data on patient's clinical characteristics, dilation technique and postprocedural follow-up were collected and statistically analyzed. Procedure effectiveness was defined as the postprocedural Eckardt score ≤ 3. : PD significantly reduced frequency of dysphagia, regurgitation, and retrosternal pain ( < 0.001). Body-weight increased significantly one month and one year after the procedure ( < 0.001). The procedural success rate was 100%. No severe complications were reported. : PD is an effective and safe treatment modality in the management of achalasia. The study limitations include a single center design with the small number of participants, not all of whom underwent manometry, gender disproportion, absence of non-responders, and a short follow-up.

摘要

气囊扩张术(PD)是贲门失弛缓症治疗中一种广泛应用的治疗方式。在许多中心无法获得先进治疗手段的地区,它尤为重要。因此,我们旨在评估PD在我们当地的有效性和安全性。:本研究回顾性分析了2013年1月至2019年12月接受PD治疗的贲门失弛缓症患者。贲门失弛缓症的诊断基于临床症状、放射学和内镜检查结果以及食管测压。收集患者的临床特征、扩张技术和术后随访数据并进行统计学分析。手术有效性定义为术后埃卡德特评分≤3。:PD显著降低了吞咽困难、反流和胸骨后疼痛的发生率(<0.001)。术后1个月和1年体重显著增加(<0.001)。手术成功率为100%。未报告严重并发症。:PD是贲门失弛缓症治疗中一种有效且安全的治疗方式。研究局限性包括单中心设计、参与者数量少、并非所有患者都进行了测压、性别不均衡、缺乏无反应者以及随访时间短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/342796bff3fc/jcm-14-05448-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/46adb0dcd915/jcm-14-05448-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/89b14de1cd7c/jcm-14-05448-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/342796bff3fc/jcm-14-05448-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/46adb0dcd915/jcm-14-05448-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/89b14de1cd7c/jcm-14-05448-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76be/12347232/342796bff3fc/jcm-14-05448-sch003.jpg

相似文献

1
Clinical Outcomes of Patients with Achalasia Following Pneumatic Dilation Treatment: A Single Center Experience.贲门失弛缓症患者经气囊扩张治疗后的临床结局:单中心经验
J Clin Med. 2025 Aug 2;14(15):5448. doi: 10.3390/jcm14155448.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis.特发性贲门失弛缓症的手术或内镜治疗效果:系统评价和网络荟萃分析。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):30-38. doi: 10.1016/S2468-1253(20)30296-X. Epub 2020 Oct 6.
4
Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia.内镜下气囊扩张术与肉毒杆菌毒素注射治疗原发性贲门失弛缓症的对比
Cochrane Database Syst Rev. 2014;2014(12):CD005046. doi: 10.1002/14651858.CD005046.pub3. Epub 2014 Dec 8.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Improvement in Health-related Quality of Life and Patient Satisfaction after Pneumatic Dilatation in Achalasia Patients.贲门失弛缓症患者气囊扩张术后健康相关生活质量及患者满意度的改善
Euroasian J Hepatogastroenterol. 2025 Jan-Jun;15(1):54-57. doi: 10.5005/jp-journals-10018-1472. Epub 2025 Jun 18.
7
Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia.腹腔镜下 Heller 心肌切开术治疗贲门失弛缓症的胃底折叠术。
Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013386. doi: 10.1002/14651858.CD013386.pub2.
8
Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia.内镜下气囊扩张术与肉毒杆菌毒素注射治疗原发性贲门失弛缓症的比较
Cochrane Database Syst Rev. 2006 Oct 18(4):CD005046. doi: 10.1002/14651858.CD005046.pub2.
9
Laparoscopic Heller myotomy is not superior to pneumatic dilation in the management of primary achalasia: Conclusions of a systematic review and meta-analysis of randomized controlled trials.在原发性贲门失弛缓症的治疗中,腹腔镜下赫勒肌切开术并不优于气囊扩张术:一项随机对照试验的系统评价和荟萃分析结论
Medicine (Baltimore). 2017 Feb;96(7):e5525. doi: 10.1097/MD.0000000000005525.
10
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.

本文引用的文献

1
Clinical characteristics and manometric findings of esophageal achalasia-a systematic review regarding differences among three subtypes.食管失弛缓症的临床特征和测压结果——三种亚型差异的系统综述
J Smooth Muscle Res. 2023;59:14-27. doi: 10.1540/jsmr.59.14.
2
Pneumatic Dilation in Geriatric Achalasia Patients.老年贲门失弛缓症患者的气囊扩张治疗。
Turk J Gastroenterol. 2023 Apr;34(4):332-338. doi: 10.5152/tjg.2023.22178.
3
Short-term outcomes after peroral endoscopic myotomy, Heller myotomy, and pneumatic dilation in patients with achalasia: a nationwide analysis.
贲门失弛缓症患者经口内镜下肌切开术、海勒肌切开术和气囊扩张术后的短期结局:一项全国性分析。
Gastrointest Endosc. 2023 May;97(5):871-879.e2. doi: 10.1016/j.gie.2023.01.004. Epub 2023 Jan 11.
4
Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomised controlled trial.经口内镜下肌切开术与气囊扩张治疗原发性贲门失弛缓症的随机对照研究:5 年随访结果
Lancet Gastroenterol Hepatol. 2022 Dec;7(12):1103-1111. doi: 10.1016/S2468-1253(22)00300-4. Epub 2022 Oct 4.
5
The comparisons of different therapeutic modalities for idiopathic achalasia: A systematic review and network meta-analysis.特发性贲门失弛缓症不同治疗方式的比较:系统评价和网络荟萃分析。
Medicine (Baltimore). 2022 Jun 17;101(24):e29441. doi: 10.1097/MD.0000000000029441.
6
Outcome of sequential dilatation in achalasia cardia patients: a prospective cohort study.贲门失弛缓症患者序贯扩张治疗的结局:一项前瞻性队列研究。
Esophagus. 2022 Jul;19(3):508-515. doi: 10.1007/s10388-021-00902-5. Epub 2022 Jan 23.
7
Safety and Efficacy of Graded Gradual Pneumatic Balloon Dilation in Idiopathic Achalasia Patients: A 24-Year Single-Center Experience.特发性贲门失弛缓症患者分级逐渐球囊扩张的安全性和疗效:24 年单中心经验。
Arch Iran Med. 2021 Dec 1;24(12):862-868. doi: 10.34172/aim.2021.129.
8
Graded pneumatic dilation in subtype I and II achalasia: long-term experience in a single center.I型和II型贲门失弛缓症的分级气囊扩张术:单中心长期经验
Ann Gastroenterol. 2022 Jan-Feb;35(1):28-33. doi: 10.20524/aog.2021.0683. Epub 2021 Dec 9.
9
Sex differences in symptoms, high-resolution manometry values and efficacy of peroral endoscopic myotomy in Chinese patients with achalasia.贲门失弛缓症中国患者症状、高分辨率测压值和经口内镜肌切开术疗效的性别差异。
J Dig Dis. 2020 Sep;21(9):490-497. doi: 10.1111/1751-2980.12922. Epub 2020 Aug 26.
10
Achalasia subtypes can be identified with functional luminal imaging probe (FLIP) panometry using a supervised machine learning process.贲门失弛缓症亚型可以使用功能腔内成像探头(FLIP)压力测量法通过有监督的机器学习过程来识别。
Neurogastroenterol Motil. 2021 Mar;33(3):e13932. doi: 10.1111/nmo.13932. Epub 2020 Jul 1.